Biological Information

Background Information:

Prostanoid receptors belong to the superfamily of G protein-coupled seven transmembrane proteins. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. Prostanoid EP4 receptors are present in brain and many peripheral tissues (e.g., ileum>thymus>spleen>lung>heart>stomach).

Family:

GPCR

Sub Family:

Prostanoid

Class:

Class A

Protein Name:

EP4

Uniprot Number:

P35408

Protein Aliases:

PGE2 receptor EP4 subtype|Prostanoid EP4 receptor

Gene Name:

PTGER4

Gene ID:

5734

Gene Aliases:

EP4

Accession Number:

NM_000958

Organism:

Human

Construct Details:

Recombinant

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Binding

Detection Method:

Radiometric

Measured Response:

Scintillation

Testing Information

Ligand:

[3H]PGE2

Ligand Kd (nM):

0.3

Ligand Concentration:

0.5 nM

Non Specific:

10 µM PGE2

Incubation:

120 min at RT

Control Inhibitor:

Prostaglandin E2

Test Concentration / Dose:

Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected.

Test Sample Requirements:

Minimum for 1) Screen: 60 µl of 10 mM stock -OR- 1 mg (pre-weighed) for 10µM final testing. 2) Dose Response: 90 µl of 10 mM stock -OR- 1 mg (pre-weighed) for a top concentration at 10 µM.

Minimum Order Quantity:

2

Turnaround Time

Standard:

10 Business Days

Reference Compound Data

PubChem ID

5280360

Name

Prostaglandin E2

Measurement

0.38nM - IC50

PubChem ID

5280363

Name

Dinoprost

Measurement

725nM - IC50

PubChem ID

5310998

Name

AH13205

Measurement

60750nM - IC50

PubChem ID

9869652

Name

AH 23848

Measurement

6975nM - IC50

Clinical Relevance

Therapeutic Area:

Inflammation/Allergy

Adverse / Beneficial Action:

EP4 receptor agonism may exhibit intestinal cytoprotection, suppress hypermotility and colon cancer, reduce inflammatory activity (ulcerative colitis) and fever as well as increase wakefulness; use in the treatment of endotoxin shock and acute myocardial infarction have also been suggested. EP4 receptor antgonism may reduce intestinal mucosal and bronchopulmonary epithelial healing.

Additional Information

Brand:

LeadHunter

Testing Location:

France - Celle L'Evescault

RELATED SOLUTIONS

Item: 1871
Item: 1872
Item: G037
Item: P1
Item: P3